BioMarin Pharmaceuticals BMRN Operating margin
Operating margin at other companies
Other financials
Where this comes from
Calculated from BioMarin Pharmaceuticals’s reported figures.
Based on trailing twelve months.
The official record: BioMarin Pharmaceuticals’s 10-Q, filed October 28, 2025, on SEC EDGAR. View the filing →
Ask your AI about BioMarin Pharmaceuticals's operating margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioMarin Pharmaceuticals's operating margin?
- BioMarin Pharmaceuticals (BMRN) reported operating margin of 19.9% in Q3 2025.
- How has BioMarin Pharmaceuticals's operating margin changed year-over-year?
- BioMarin Pharmaceuticals's operating margin increased by 56.4% year-over-year, from 12.7% to 19.9%.
- What is the long-term trend for BioMarin Pharmaceuticals's operating margin?
- Over 4 years (2020 to 2024), BioMarin Pharmaceuticals's operating margin has grown at a 64.2% compound annual growth rate (CAGR), from -2.3% to 17%.
- What does operating margin mean?
- The profit left from core operations for every dollar of sales, before interest and taxes.
- How do you interpret operating margin?
- Expanding operating margin shows operating leverage — revenue growing faster than the cost base. Compression points to rising overhead, pricing pressure, or investment ahead of revenue.
- How does operating margin compare across companies?
- Strong cross-company signal within a sector. Capital-light businesses sustain higher operating margins than capital-intensive ones.